{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:00:47Z","timestamp":1784818847787,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-LCYJ-DBZ-08"],"award-info":[{"award-number":["2022-LCYJ-DBZ-08"]}]},{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-LCYJ-MS-07"],"award-info":[{"award-number":["2022-LCYJ-MS-07"]}]},{"name":"Project of Chinese Hospital Reform and Development Institute, Nanjing University","award":["NDYG2022017"],"award-info":[{"award-number":["NDYG2022017"]}]},{"name":"Aid project of Nanjing Drum Tower Hospital Health, Education & Research Foundation","award":["NDYG2022017"],"award-info":[{"award-number":["NDYG2022017"]}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["JQX21002"],"award-info":[{"award-number":["JQX21002"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"crossref","award":["BK20211004"],"award-info":[{"award-number":["BK20211004"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02561-1","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T12:18:18Z","timestamp":1731500298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["HBeAg-positive CHB patients with indeterminate phase associated with a high risk of significant fibrosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuanyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"issue":"10381","key":"2561_CR1","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF, Hepatitis. B Lancet. 2023;401(10381):1039\u201352.","journal-title":"B Lancet"},{"issue":"4","key":"2561_CR2","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"2","key":"2561_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"5","key":"2561_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/apt.17272","volume":"57","author":"J Wang","year":"2023","unstructured":"Wang J, Yan X, Zhu L, et al. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Aliment Pharmacol Ther. 2023;57(5):464\u201374.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"2561_CR5","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/jvh.13511","volume":"28","author":"K Yao","year":"2021","unstructured":"Yao K, Liu J, Wang J, et al. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone. J Viral Hepat. 2021;28(7):1025\u201333.","journal-title":"J Viral Hepat"},{"issue":"8","key":"2561_CR6","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","volume":"20","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Li X, Le MH, et al. Natural history and Hepatocellular Carcinoma Risk in untreated chronic Hepatitis B patients with Indeterminate Phase. Clin Gastroenterol Hepatol. 2022;20(8):1803\u201312. e5.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2561_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12985-024-02368-0","volume":"21","author":"J Wang","year":"2024","unstructured":"Wang J, Zhu L, Zhang Z, et al. Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase. Virol J. 2024;21(1):127.","journal-title":"Virol J"},{"issue":"2","key":"2561_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3350\/cmh.2022.0322","volume":"29","author":"JJ Yoo","year":"2023","unstructured":"Yoo JJ, Park SY, Moon JE, et al. Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase. Clin Mol Hepatol. 2023;29(2):482\u201395.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"2561_CR9","doi-asserted-by":"publisher","first-page":"e00323","DOI":"10.14309\/ctg.0000000000000323","volume":"12","author":"Y Qu","year":"2021","unstructured":"Qu Y, Song YY, Chen CW, et al. Diagnostic performance of FibroTouch Ultrasound Attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Clin Transl Gastroenterol. 2021;12(4):e00323.","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"2561_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","volume":"13","author":"PJ Scheuer","year":"1991","unstructured":"Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol. 1991;13(3):372\u20134.","journal-title":"J Hepatol"},{"issue":"6","key":"2561_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"2","key":"2561_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"10","key":"2561_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/apt.16097","volume":"52","author":"JH Kao","year":"2020","unstructured":"Kao JH, Hu TH, Jia J, et al. East Asia expert opinion on treatment initiation for chronic hepatitis B. Aliment Pharmacol Ther. 2020;52(10):1540\u201350.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2561_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.21724","volume":"46","author":"CK Hui","year":"2007","unstructured":"Hui CK, Leung N, Yuen ST, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007;46(2):395\u2013401.","journal-title":"Hepatology"},{"issue":"6","key":"2561_CR15","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s10620-021-07009-y","volume":"67","author":"MH Lin","year":"2022","unstructured":"Lin MH, Li HQ, Zhu L, et al. Liver fibrosis in the natural course of Chronic Hepatitis B viral infection: a systematic review with Meta-analysis. Dig Dis Sci. 2022;67(6):2608\u201326.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"2561_CR16","doi-asserted-by":"publisher","first-page":"e0203220","DOI":"10.1371\/journal.pone.0203220","volume":"13","author":"YF Xing","year":"2018","unstructured":"Xing YF, Zhou DQ, He JS, et al. Clinical and histopathological features of chronic hepatitis B virus infected patients with high HBV-DNA viral load and normal alanine aminotransferase level: a multicentre-based study in China. PLoS ONE. 2018;13(9):e0203220.","journal-title":"PLoS ONE"},{"issue":"4","key":"2561_CR17","first-page":"325","volume":"32","author":"L Liu","year":"2024","unstructured":"Liu L, Dong ZJ, Chang LX, et al. HBeAg-positive patients hepatic tissue inflammatory activity and influencing factors during normal ALT and indeterminate phases. Zhonghua Gan Zang Bing Za Zhi. 2024;32(4):325\u201331.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"2561_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65\u201373.","journal-title":"JAMA"},{"issue":"1","key":"2561_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cgh.2009.09.026","volume":"8","author":"JD Kim","year":"2010","unstructured":"Kim JD, Choi JY, Bae SH, et al. Hepatitis B virus load in serum does not reflect histologic activity in patients with decompensated cirrhosis. Clin Gastroenterol Hepatol. 2010;8(1):60\u20135.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2561_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12876-014-0218-6","volume":"14","author":"S Praneenararat","year":"2014","unstructured":"Praneenararat S, Chamroonkul N, Sripongpun P, Kanngurn S, Jarumanokul R, Piratvisuth T. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication. BMC Gastroenterol. 2014;14:218.","journal-title":"BMC Gastroenterol"},{"issue":"16","key":"2561_CR21","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3748\/wjg.v29.i16.2479","volume":"29","author":"SW Jiang","year":"2023","unstructured":"Jiang SW, Lian X, Hu AR, et al. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication. World J Gastroenterol. 2023;29(16):2479\u201394.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2561_CR22","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1002\/jmv.24000","volume":"86","author":"Q Xie","year":"2014","unstructured":"Xie Q, Hu X, Zhang Y, Jiang X, Li X, Li J. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B. J Med Virol. 2014;86(11):1828\u201337.","journal-title":"J Med Virol"},{"issue":"12","key":"2561_CR23","first-page":"1309","volume":"30","author":"Guidelines for the prevention","year":"2022","unstructured":"Guidelines for the prevention. And treatment of chronic hepatitis B (version 2022). Zhonghua Gan Zang Bing Za Zhi. 2022;30(12):1309\u201331.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"2","key":"2561_CR24","doi-asserted-by":"publisher","first-page":"e32622","DOI":"10.1371\/journal.pone.0032622","volume":"7","author":"WK Seto","year":"2012","unstructured":"Seto WK, Lai CL, Ip PP, et al. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. PLoS ONE. 2012;7(2):e32622.","journal-title":"PLoS ONE"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02561-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T13:07:03Z","timestamp":1731503223000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02561-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2561"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02561-1","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,13]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Nanjing Drum Tower Hospital and each participate site.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"287"}}